Defining promiscuous MHC class II helper T-cell epitopes for the HER2/neu tumor antigen.
2000 · PubMed · 139 citations
H
Hiroya Kobayashi
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
157
Papers
3.0K
Citations
32
h-index
69
i10-index
Hiroya Kobayashi is an academic researcher from Asahikawa Medical University. The author has contributed to research in topics: Immunotherapy and Immune Responses & Immune Cell Function and Interaction & Cancer Immunotherapy and Biomarkers. The author has an h-index of 32, co-authored 134 publications.
ORCID: 0000-0001-5222-8961Papers by this author
worksEGFR inhibitors augment antitumour helper T-cell responses of HER family-specific immunotherapy
2013 · British Journal of Cancer · 66 citations
https://doi.org/10.1038/bjc.2013.577
Six-transmembrane epithelial antigen of the prostate and enhancer of zeste homolog 2 as immunotherapeutic targets for lung cancer
2011 · Journal of Translational Medicine · 32 citations
https://doi.org/10.1186/1479-5876-9-191
PD-L1-specific helper T-cells exhibit effective antitumor responses: new strategy of cancer immunotherapy targeting PD-L1 in head and neck squamous cell carcinoma
2019 · Journal of Translational Medicine · 17 citations
https://doi.org/10.1186/s12967-019-1957-5
Severe spruelike enteropathy and collagenous colitis caused by olmesartan
2021 · BMC Gastroenterology · 15 citations
https://doi.org/10.1186/s12876-021-01926-y
MHC-Binding Peptides as Immunotherapeutics for Cancer
2000 · Immunological Investigations · 11 citations
https://doi.org/10.3109/08820130009062291
Research topics
topicsChat about Author
Papers
Chat
Click to start Chat